An interventional study of Exergaming in Frailty in Older Adults, sponsored by Hong Kong Metropolitan University. Recruiting at 1 site in Hong Kong. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-05-14.
Sponsored by Hong Kong Metropolitan University · Not applicable, Interventional, and Other
This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents
Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents.
To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.
Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.
All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.
1,199 studies on the registry are indexed under Frailty; 430 are open to participants now.
This study's planned enrollment of 30 is below the median of 80 across 681 interventional studies indexed under Frailty.
Browse Frailty studies →Hong Kong Metropolitan University is the lead sponsor of 56 studies on the registry; 31 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Wait list control, after post-test, 12 week supervised exercise intervention
12-week exergaming intervention
Behavioral: Exergaming
This intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming.
upper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T0: baseline
upper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T1: 6 week
upper extremity endurance
upper extremity endurance measured by arm curl test
Time frame: T2: immediately (1 week) after intervention
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T0: baseline
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T1: 6 week
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Time frame: T2: immediately (1 week) after intervention
upper extremity strength
upper extremity strength measured by handheld dynamometer
Time frame: T0: baseline
upper extremity strength
upper extremity strength measured by handheld dynamometer
Time frame: T1: 6 week
upper extremity strength
upper extremity strength measured by handheld dynamometer
Time frame: T2: immediately (1 week) after intervention
lung capacity
lung capacity measured by peak flow meter
Time frame: T0: baseline
lung capacity
lung capacity measured by peak flow meter
Time frame: T1: 6 week
lung capacity
lung capacity measured by peak flow meter
Time frame: T2: immediately (1 week) after intervention
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T0: baseline
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T1: 6 week
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Time frame: T2: immediately (1 week) after intervention
feasibility, acceptability and appropriateness of intervention
feasibility, acceptability and appropriateness of intervention measured by questionnaire
Time frame: T2: immediately (1 week) after intervention
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T0: baseline
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T1: 6 week
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Time frame: T2: immediately (1 week) after intervention
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T0: baseline
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T1: 6 week
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Time frame: T2: immediately (1 week) after intervention
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hong Kong Metropolitan University